Study assessing the effect of Ledipasvir/sofosbuvir in Treatment-Naïve Patients with Non-Cirrhotic, Genotype 1 Hepatitis C: Real-World Experience from the Trio Network
Latest Information Update: 16 May 2018
Price :
$35 *
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 14 Apr 2018 Results (n=212) of a subanalysis presented at The International Liver Congress 2018.
- 07 Jun 2016 New trial record
- 25 May 2016 Results presented at the 21st Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research